Indefinite Delivery Contract SPE2DR25D3902

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded this $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which runs through December 2026, aims to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support, including brand-name, generic, and specialty medications, as well as related medical supplies and equipment, to various DoD customers, the U.S. Coast Guard, designated providers, and other government agencies. The contract encompasses a 30-month base period with three 30-month option periods, and will cover medical commodities across multiple therapeutic areas to support normal operations, contingencies, and war readiness material requirements globally. The contract was awarded through open competition with no set-aside requirements.

This IDC represents a key component of DLA's strategy to diversify its pharmaceutical procurement across multiple suppliers to enhance resiliency and access to vital medical products, particularly during times of contingency or natural disaster. The agency intends to make multiple regional awards to at least three different contractors for the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet (CONUS/OCONUS) line items, in addition to a separate award for a Back-Up Supplier covering all regions. This approach aims to ensure no single supplier has the entirety of the DoD's pharmaceutical requirements, which will improve the Department's ability to maintain critical medical supply chains.